Molecularly targeted treatment with erlotinib and bevacizumab as second-line treatment for inoperable biliary tract cancer

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato2012
StatusUdgivet - 2012
BegivenhedESMO 2012 - Barcelona, Spanien
Varighed: 27. jun. 201230. jun. 2012

Konference

KonferenceESMO 2012
LandSpanien
ByBarcelona
Periode27/06/201230/06/2012

Citationsformater